Search BRITE hierarchies

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    11  Agents affecting central nervous system
      112  Hypnotics and sedatives, anxiolytics
        1129  Others
          D01564  Rilmazafone hydrochloride hydrate (JP18)

Drug groups [BR:br08330]
  Neuropsychiatric agent
    DG01835  Benzodiazepine sedative-hypnotics
      DG01307  Rilmazafone
        D01564  Rilmazafone hydrochloride hydrate
    DG03202  Hypnotic
      DG01307  Rilmazafone
        D01564  Rilmazafone hydrochloride hydrate
    DG01567  GABA-A receptor agonist
      DG01307  Rilmazafone
        D01564  Rilmazafone hydrochloride hydrate
  Metabolizing enzyme substrate
    DG01633  CYP3A/CYP3A4 substrate
      DG02913  CYP3A4 substrate
        DG01307  Rilmazafone
          D01564  Rilmazafone hydrochloride hydrate
    DG02970  CES substrate
      DG01307  Rilmazafone
        D01564  Rilmazafone hydrochloride hydrate

Drug classes [BR:br08332]
  Neuropsychiatric agent
    DG03202  Hypnotic
      D01564  Rilmazafone hydrochloride hydrate

Target-based classification of drugs [BR:br08310]
  Ion channels
    Ligand-gated ion channels
      GABA (ionotropic)
        GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]
          D01564  Rilmazafone hydrochloride hydrate (JP18) <JP>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D01564  Rilmazafone hydrochloride hydrate
    D01564  Rilmazafone hydrochloride tablets

Drug metabolizing enzymes and transporters [br08309.html]
  D01564